[HTML][HTML] Systematic review and meta-analysis of second-generation antidepressants for the treatment of older adults with depression: questionable benefit and …

L Mallery, T MacLeod, M Allen, P McLean-Veysey… - BMC geriatrics, 2019 - Springer
Background Frail older adults are commonly prescribed antidepressants. Yet, there is little
evidence to determine the efficacy and safety of antidepressants to treat depression with …

Patterns of opioid prescribing by dentists in a pediatric population: a retrospective observational study

…, KO Jimoh, W Singleton, P McLean-Veysey… - … Open Access Journal, 2019 - cmajopen.ca
Background: Dentists are regular prescribers of opioid analgesic medications; however,
there are few published data on their prescribing practices for children. The aim of this study …

Interaction between clopidogrel and proton pump inhibitors

MJ Allen, P McLean-Veysey - CMAJ, 2009 - Can Med Assoc
The study by David Juurlink and colleagues is a significant contribution to the awareness of
potential interactions between clopidogrel and proton pump inhibitors. 1 However, a number …

Coxibs and cardiovascular risk

MJ Allen, P McLean-Veysey, I Fleming - CMAJ, 2005 - Can Med Assoc
1. Cotter J, Wooltorton E. New restrictions on celecoxib (Celebrex) use and the withdrawal
of valdecoxib (Bextra). CMAJ 2005; 172 (10): 1299. 2. Mukherjee D, Nissen SE, Topol EJ. …

Syed AH Zaidi

MJ Allen, P McLean-Veysey, I Fleming - scholar.archive.org
The wrong stuff Page 1 cardiovascular system.However, the COX-2 enzyme might be exerting
detrimental effects elsewhere, because analysis of protein extracts from normal arteries …

Interaction between clopidogrel and proton pump inhibitors/Three of the authors respond

MJ Allen, DN Juurlink, JV Tu - … Medical Association. Journal, 2009 - search.proquest.com
… Allen and McLean-Veysey suggest that pantoprazole and other proton pump inhibitors
are not significantly different from each other on the basis of the observation that the point esti…

Coxibs and cardiovascular risk

SAH Zaidi - CMAJ, 2005 - Can Med Assoc
Jill Cotter and Eric Wooltorton1 highlight the importance of differences in cyclooxygenase 2 (COX-2)
selectivity as a potential explanation for the prothrombotic effects of coxibs. However…

The wrong stuff

IMM Connor - CMAJ, 2005 - Can Med Assoc
1. Cotter J, Wooltorton E. New restrictions on celecoxib (Celebrex) use and the withdrawal
of valdecoxib (Bextra). CMAJ 2005; 172 (10): 1299. 2. Mukherjee D, Nissen SE, Topol EJ. …

[PDF][PDF] Association of Faculties of Pharmacy of Canada Poster Presentations

J Slaunwhite, I Sketris - journals.library.ualberta.ca
Objective: Although skin cancer is the most common cancer in Canada (Canadian Cancer
Society, 2008), preventative behaviors and regular screening can dramatically reduce the …

Qualitative perspectives on a facilitated change in provincial pharmacare coverage

PL Twohig, W Putnam, D Frail - … Pharmacists Journal/Revue …, 2005 - journals.sagepub.com
Background: During 2000, Nova Scotia's Department of Health implemented policy changes
and educational interventions to encourage a switch from wet nebulization therapy to dry-…